Literature DB >> 3060000

Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation.

T J Walsh1, P A Pizzo.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3060000     DOI： 10.1146/annurev.mi.42.100188.002505

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN： 0066-4227            Impact factor:   15.500


× No keyword cloud information.
  32 in total

1.  Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.

Authors:  T J Walsh; P A Pizzo
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

2.  In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus.

Authors:  Cornelia Lass-Flörl; Alexandra Rief; Sandra Leitner; Cornelia Speth; Reinhard Würzner; Manfred P Dierich
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

3.  Surveillance of nosocomial fungal infections in a burn care unit.

Authors:  A Chakrabarti; N Nayak; P S Kumar; P Talwar; P S Chari; D Panigrahi
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

Review 4.  Antifungal agents: chemotherapeutic targets and immunologic strategies.

Authors:  N H Georgopapadakou; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

5.  Value of detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidosis.

Authors:  G Quindós; J Pontón; R Cisterna; D W Mackenzie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

6.  Antifungal activities and cytotoxicity studies of six new azasordarins.

Authors:  E Herreros; M J Almela; S Lozano; F Gomez de las Heras; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

7.  Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.

Authors:  N Khardori; H Nguyen; L C Stephens; L Kalvakuntla; B Rosenbaum; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 8.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi.

Authors:  E Herreros; C M Martinez; M J Almela; M S Marriott; F G De Las Heras; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  Molecular epidemiology of nosocomial invasive aspergillosis.

Authors:  H Girardin; J Sarfati; F Traoré; J Dupouy Camet; F Derouin; J P Latgé
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.